Market Cap 55.46B
Revenue (ttm) 9.26B
Net Income (ttm) 2.49B
EPS (ttm) N/A
PE Ratio 19.66
Forward PE 18.41
Profit Margin 26.86%
Debt to Equity Ratio 1.31
Volume 7,044,922
Avg Vol 5,539,836
Day's Range N/A - N/A
Shares Out 440.69M
Stochastic %K 25%
Beta 0.97
Analysts Strong Sell
Price Target $159.60

Company Profile

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermato...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 973 822 7000
Address:
10 Sylvan Way, Parsippany, United States
Godwins26
Godwins26 Jan. 15 at 2:06 PM
Watchlist today 😊 $IVP $CHWY $WOOF $ZTS $FRPT
0 · Reply
Godwins26
Godwins26 Jan. 15 at 4:29 AM
Watchlist 🐕 $IVP up 256% $CHWY $WOOF $ZTS $FRPT
0 · Reply
Godwins26
Godwins26 Jan. 15 at 4:08 AM
Animal Watchlist 🐕 $IVP up 260% $CHWY $WOOF $ZTS $FRPT
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jan. 14 at 2:30 PM
$PETV Just Dropped News 📰 Digital Landia’s AgenticPet surpassed 1,000+ active beta users in under 72 hours, signaling strong demand for AI-powered preventive pet healthcare. Key highlights: 🔸1,000+ beta users onboarded under 72 hours 🔸 Confirms demand for proactive, AI-driven pet health monitoring 🔸 Powered by 10 specialized AI agents (Veterinarian, Behaviorist, Geneticist, Radiologist, etc.) 🔸 Early users report detection of health, stress, and behavioral issues previously unnoticed 🔸 Backed by an exclusive 10-year partnership with PetVivo Holdings 🔸 Partnership provides access to ~8,500 veterinary clinics nationwide Momentum is building and PETV sits at the center of AI-driven preventive pet care. Communicated Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/ Sector Peers: $ZTS $IDXX $ELAN $PAHC
0 · Reply
OnlyFibs
OnlyFibs Jan. 14 at 1:10 AM
$ZTS is currently navigating a tight consolidation range after a period of volatility. While the long-term trend has been challenged, the stock is showing signs of stabilizing as it holds near its recently raised dividend level and approaches its Q4 earnings report on February 12th. Institutional interest remains a tailwind, with recent stake increases providing a floor for the price action. Key Levels to Confirm: 🐂 Bulls: Need a clean daily close above $127.23 to confirm a short-term reversal and target the next major resistance at $130.00. 🐻 Bears: A break below the $123.31 intraday low risks a retest of the critical 52-week support at $115.25. #hovdid
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 13 at 4:53 PM
$ZTS Current Stock Price: $124.19 Contracts to trade: $125 ZTS Jan 16 2026 Call Entry: $1.00 Exit: $1.87 ROI: 87% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
scalpemfast
scalpemfast Jan. 10 at 4:16 AM
$ZTS ,$AMGN ,$AMZN, put this on your screen!!! It will happen. My opinion
1 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jan. 6 at 2:35 PM
$PETV : From Vet Devices to AI Powerhouse 🐾 PetVivo Holdings develops FDA approved regenerative veterinary devices and is now leveraging its installed base to launch a high-margin AI diagnostic platform. The foundation➡️ The Device Business: ➖ SPRYNG & PrecisePRP FDA-approved regenerative veterinary devices ➖1,000+ veterinary clinics actively using PetVivo products ➖7,300+ veterinarians in the distribution network ➖30% gross margins with stable, repeat revenue The Catalyst ➡️The AI Platform: ➖ http://PetVivo.ai launching Q1 2026 (≈ 90 days away) ➖ 10 specialized AI diagnostic agents ➖ 80–90% gross margins, a massive step-change from devices The market opportunity: Wall Street is valuing PetVivo as a low multiple veterinary device company (~$45M market cap), while the company is evolving into an AI-driven platform that could justify a $360M$1.35B+ valuation. Communicated Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/ Sector Peers: $ZTS $IDXX $ELAN $PAHC
1 · Reply
Tjk81
Tjk81 Jan. 6 at 4:42 AM
$ZTS one question with this stock. If you look at their quarterly report, the large dip is due to OA medicine. But the newest growth drivers are all OA medicine. So even though Librela gets bad rep, every other aspect of their business is good and growing. And the growth is actually outgrowing the fall of librela sales; so it’s like why is it priced as a dying company. Idk very interesting
1 · Reply
NavalnyTheGreat
NavalnyTheGreat Jan. 5 at 4:40 PM
$ZTS Nightmare on Elm Street with this stock. Just terrible
0 · Reply
Latest News on ZTS
Trade Tracker: Stephanie Link buys mores Zoetis

Dec 23, 2025, 4:04 PM EST - 24 days ago

Trade Tracker: Stephanie Link buys mores Zoetis


Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst

Nov 21, 2025, 12:24 PM EST - 2 months ago

Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst


Zoetis to Host Innovation Webcast

Nov 19, 2025, 8:30 AM EST - 2 months ago

Zoetis to Host Innovation Webcast


Zoetis: A High-Quality Compounder Now On Sale?

Nov 14, 2025, 11:35 AM EST - 2 months ago

Zoetis: A High-Quality Compounder Now On Sale?


Zoetis Inc. (ZTS) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 4:16 PM EST - 2 months ago

Zoetis Inc. (ZTS) Q3 2025 Earnings Call Transcript


Zoetis Stock Outlook Clouded By Rising Competitive Pressures

Nov 4, 2025, 1:15 PM EST - 2 months ago

Zoetis Stock Outlook Clouded By Rising Competitive Pressures


Zoetis: No Longer A Growth Stock

Nov 4, 2025, 12:41 PM EST - 2 months ago

Zoetis: No Longer A Growth Stock


Zoetis Announces Third Quarter 2025 Results

Nov 4, 2025, 7:00 AM EST - 2 months ago

Zoetis Announces Third Quarter 2025 Results


Buy Zoetis Stock Today?

Oct 31, 2025, 10:10 AM EDT - 2 months ago

Buy Zoetis Stock Today?


Zoetis Appoints Stephanie Tilenius to its Board of Directors

Oct 28, 2025, 8:30 AM EDT - 2 months ago

Zoetis Appoints Stephanie Tilenius to its Board of Directors


Zoetis Stock: Outlook Remains Muted

Oct 21, 2025, 6:48 AM EDT - 3 months ago

Zoetis Stock: Outlook Remains Muted


Zoetis Declares Fourth Quarter 2025 Dividend

Oct 9, 2025, 4:15 PM EDT - 3 months ago

Zoetis Declares Fourth Quarter 2025 Dividend


Top 15 High-Growth Dividend Stocks For October 2025

Oct 1, 2025, 10:58 PM EDT - 3 months ago

Top 15 High-Growth Dividend Stocks For October 2025

ACN DPZ EOG FDX INTU MSCI NDSN


Pet Pain For Investor Gain

Sep 26, 2025, 10:19 AM EDT - 4 months ago

Pet Pain For Investor Gain


Zoetis: A Solid Dividend Growth Investment For The Long Haul

Sep 1, 2025, 4:14 AM EDT - 4 months ago

Zoetis: A Solid Dividend Growth Investment For The Long Haul


Godwins26
Godwins26 Jan. 15 at 2:06 PM
Watchlist today 😊 $IVP $CHWY $WOOF $ZTS $FRPT
0 · Reply
Godwins26
Godwins26 Jan. 15 at 4:29 AM
Watchlist 🐕 $IVP up 256% $CHWY $WOOF $ZTS $FRPT
0 · Reply
Godwins26
Godwins26 Jan. 15 at 4:08 AM
Animal Watchlist 🐕 $IVP up 260% $CHWY $WOOF $ZTS $FRPT
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jan. 14 at 2:30 PM
$PETV Just Dropped News 📰 Digital Landia’s AgenticPet surpassed 1,000+ active beta users in under 72 hours, signaling strong demand for AI-powered preventive pet healthcare. Key highlights: 🔸1,000+ beta users onboarded under 72 hours 🔸 Confirms demand for proactive, AI-driven pet health monitoring 🔸 Powered by 10 specialized AI agents (Veterinarian, Behaviorist, Geneticist, Radiologist, etc.) 🔸 Early users report detection of health, stress, and behavioral issues previously unnoticed 🔸 Backed by an exclusive 10-year partnership with PetVivo Holdings 🔸 Partnership provides access to ~8,500 veterinary clinics nationwide Momentum is building and PETV sits at the center of AI-driven preventive pet care. Communicated Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/ Sector Peers: $ZTS $IDXX $ELAN $PAHC
0 · Reply
OnlyFibs
OnlyFibs Jan. 14 at 1:10 AM
$ZTS is currently navigating a tight consolidation range after a period of volatility. While the long-term trend has been challenged, the stock is showing signs of stabilizing as it holds near its recently raised dividend level and approaches its Q4 earnings report on February 12th. Institutional interest remains a tailwind, with recent stake increases providing a floor for the price action. Key Levels to Confirm: 🐂 Bulls: Need a clean daily close above $127.23 to confirm a short-term reversal and target the next major resistance at $130.00. 🐻 Bears: A break below the $123.31 intraday low risks a retest of the critical 52-week support at $115.25. #hovdid
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 13 at 4:53 PM
$ZTS Current Stock Price: $124.19 Contracts to trade: $125 ZTS Jan 16 2026 Call Entry: $1.00 Exit: $1.87 ROI: 87% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
scalpemfast
scalpemfast Jan. 10 at 4:16 AM
$ZTS ,$AMGN ,$AMZN, put this on your screen!!! It will happen. My opinion
1 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jan. 6 at 2:35 PM
$PETV : From Vet Devices to AI Powerhouse 🐾 PetVivo Holdings develops FDA approved regenerative veterinary devices and is now leveraging its installed base to launch a high-margin AI diagnostic platform. The foundation➡️ The Device Business: ➖ SPRYNG & PrecisePRP FDA-approved regenerative veterinary devices ➖1,000+ veterinary clinics actively using PetVivo products ➖7,300+ veterinarians in the distribution network ➖30% gross margins with stable, repeat revenue The Catalyst ➡️The AI Platform: ➖ http://PetVivo.ai launching Q1 2026 (≈ 90 days away) ➖ 10 specialized AI diagnostic agents ➖ 80–90% gross margins, a massive step-change from devices The market opportunity: Wall Street is valuing PetVivo as a low multiple veterinary device company (~$45M market cap), while the company is evolving into an AI-driven platform that could justify a $360M$1.35B+ valuation. Communicated Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/ Sector Peers: $ZTS $IDXX $ELAN $PAHC
1 · Reply
Tjk81
Tjk81 Jan. 6 at 4:42 AM
$ZTS one question with this stock. If you look at their quarterly report, the large dip is due to OA medicine. But the newest growth drivers are all OA medicine. So even though Librela gets bad rep, every other aspect of their business is good and growing. And the growth is actually outgrowing the fall of librela sales; so it’s like why is it priced as a dying company. Idk very interesting
1 · Reply
NavalnyTheGreat
NavalnyTheGreat Jan. 5 at 4:40 PM
$ZTS Nightmare on Elm Street with this stock. Just terrible
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 2 at 8:40 PM
$ZTS Current Stock Price: $126.07 Contracts to trade: $125 ZTS Jan 16 2026 Call Entry: $2.85 Exit: $3.86 ROI: 36% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
handmedown1
handmedown1 Jan. 2 at 1:44 PM
$ZTS 👌 wow
0 · Reply
Ojimenez59
Ojimenez59 Jan. 2 at 6:47 AM
$ZTS need more shares
0 · Reply
DorotheaNewell809
DorotheaNewell809 Dec. 31 at 5:56 PM
$AZO $TRP $NDAQ $ZTS $VALE Nicely expressed
0 · Reply
GeorgiaBroome1089
GeorgiaBroome1089 Dec. 30 at 2:48 PM
$LLY $BMY $GILD $ZTS $REGN Breakthrough therapies becoming major growth catalysts https://howardlindzonanalysis.beehiiv.com/p/the-next-big-market-wave-is-forming-be-early-not-late
0 · Reply
SPYmyQQQ
SPYmyQQQ Dec. 26 at 10:24 PM
🏛️ 🚀 $ZTS up ⬆️5.60% since our entry $119.62 on Dec 11, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
SPYmyQQQ
SPYmyQQQ Dec. 26 at 5:08 PM
🎯 Target Hit 🏁 📨 From Dec 22, 2025 🏛️ $ZTS 💵 Entry: $122.7300 ✅ Exit: $126.0683 💰 P/L: +2.72% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
OnlyFibs
OnlyFibs Dec. 26 at 1:28 AM
The $ZTS tape is officially telling a new story as we head into 2026. 😤🧬 Action: Defending the $122.55 horizontal floor while management launches a massive $1.8B buyback program. Alpha: Institutional inflows just hit $15.5B—the whales are mopping up the floor while retail panics over the sales forecast. 🔋 Trigger: Reclaiming $126.20 ignites the run back toward the $158 analyst average. 🚀 Smart money is loading the 29% upside while the "valuation" bears ignore the fresh 6% dividend hike. 🚢💎 #hovdid
0 · Reply
DilithiumDelta
DilithiumDelta Dec. 24 at 6:38 PM
$ZTS Long‑horizon outcomes depend on proof that pricing power can persist through normalization phases, with outcomes shaped by timing and discipline. Failure to deliver could compress multiples quickly.
0 · Reply
OnlyFibs
OnlyFibs Dec. 24 at 6:12 PM
$ZTS 🎯
0 · Reply
tiostocks
tiostocks Dec. 24 at 3:19 AM
$CHWY $ZTS 🟢✔️ https://thedogsfence.com
0 · Reply
jdlman
jdlman Dec. 23 at 5:23 PM
$ZTS Stephanie link loves this stock
1 · Reply